JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
- PMID: 36218416
- DOI: 10.1093/rheumatology/keac592
JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
Comment on
-
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.Rheumatology (Oxford). 2023 Apr 3;62(4):1594-1604. doi: 10.1093/rheumatology/keac440. Rheumatology (Oxford). 2023. PMID: 35920788
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
